Korine van Dijk1, Konstantinos Droutsas2, Jingzhen Hou3, Sassan Sangsari3, Vasilios S Liarakos1, Gerrit R J Melles4. 1. Netherlands Institute for Innovative Ocular Surgery, Rotterdam, Netherlands; Melles Cornea Clinic, Rotterdam, Netherlands. 2. Netherlands Institute for Innovative Ocular Surgery, Rotterdam, Netherlands; Melles Cornea Clinic, Rotterdam, Netherlands; Universitätsklinikum Gießen und Marburg GmbH, Standort Marburg, Germany. 3. Netherlands Institute for Innovative Ocular Surgery, Rotterdam, Netherlands; Amnitrans EyeBank, Rotterdam, Netherlands. 4. Netherlands Institute for Innovative Ocular Surgery, Rotterdam, Netherlands; Melles Cornea Clinic, Rotterdam, Netherlands; Amnitrans EyeBank, Rotterdam, Netherlands. Electronic address: research@niios.com.
Abstract
PURPOSE: To evaluate corneal higher-order aberrations (HOAs) and backscattered light before and after Descemet membrane endothelial keratoplasty (DMEK) and their correlation with visual outcome. DESIGN: Retrospective study. METHODS: In a total of 118 consecutive eyes of 118 patients who underwent uneventful DMEK for Fuchs endothelial dystrophy at a tertiary referral center, best spectacle-corrected visual acuity (BSCVA), corneal HOAs, and backscattered light were evaluated preoperatively and at 6 months postoperatively. Outcome data were compared to an age-matched control group with uncomplicated eyes (n = 27). RESULTS: Compared to the control group, Fuchs endothelial dystrophy eyes, before as well as 6 months after DMEK, showed higher values of anterior and posterior HOAs and backscattered light (P < .033). Postoperative anterior HOAs and backscattered light (0-2 mm) were associated with lower 6-month BSCVA (positively related with logMAR BSCVA) (P ≤ .020). Anterior corneal HOAs did not change from preoperative to 6 months after DMEK (P = .649), while total posterior HOAs (RMS third to sixth Zernike order) and haze decreased (P < .001). CONCLUSIONS: Anterior and posterior corneal HOAs, as well as backscattered light from the cornea, were elevated in eyes suffering from Fuchs endothelial dystrophy and remained higher throughout 6 months after DMEK. If present, anterior surface irregularities and anterior corneal haze may be the most important limiting factors in visual rehabilitation after DMEK.
PURPOSE: To evaluate corneal higher-order aberrations (HOAs) and backscattered light before and after Descemet membrane endothelial keratoplasty (DMEK) and their correlation with visual outcome. DESIGN: Retrospective study. METHODS: In a total of 118 consecutive eyes of 118 patients who underwent uneventful DMEK for Fuchs endothelial dystrophy at a tertiary referral center, best spectacle-corrected visual acuity (BSCVA), corneal HOAs, and backscattered light were evaluated preoperatively and at 6 months postoperatively. Outcome data were compared to an age-matched control group with uncomplicated eyes (n = 27). RESULTS: Compared to the control group, Fuchs endothelial dystrophy eyes, before as well as 6 months after DMEK, showed higher values of anterior and posterior HOAs and backscattered light (P < .033). Postoperative anterior HOAs and backscattered light (0-2 mm) were associated with lower 6-month BSCVA (positively related with logMAR BSCVA) (P ≤ .020). Anterior corneal HOAs did not change from preoperative to 6 months after DMEK (P = .649), while total posterior HOAs (RMS third to sixth Zernike order) and haze decreased (P < .001). CONCLUSIONS: Anterior and posterior corneal HOAs, as well as backscattered light from the cornea, were elevated in eyes suffering from Fuchs endothelial dystrophy and remained higher throughout 6 months after DMEK. If present, anterior surface irregularities and anterior corneal haze may be the most important limiting factors in visual rehabilitation after DMEK.
Authors: Matthew J Duggan; Jennifer Rose-Nussbaumer; Charles C Lin; Ariana Austin; Paula C Labadzinzki; Winston D Chamberlain Journal: Ophthalmology Date: 2019-02-16 Impact factor: 12.079
Authors: Maria Satue; Miriam Idoipe; Alicia Gavin; Maria Romero-Sanz; Vasilios S Liarakos; Antonio Mateo; Elena Garcia-Martin; Alejandro Blasco-Martinez; Antonio Sanchez-Perez Journal: J Ophthalmol Date: 2018-09-23 Impact factor: 1.909